NCT00358319View on ClinicalTrials.gov

Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Malignant Melanoma
Interventions
DRUG

Karenitecin

DRUG

Valproic Acid

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Sponsors
All Listed Sponsors
collaborator

BioNumerik Pharmaceuticals, Inc.

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00358319 - Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma | Biotech Hunter | Biotech Hunter